These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 23241952)

  • 1. The expression and concentration of CD40 ligand in normal pregnancy, preeclampsia, and hemolytic anemia, elevated liver enzymes and low platelet count (HELLP) syndrome.
    Azzam HA; Abousamra NK; Goda H; El-Shouky R; El-Gilany AH
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):71-5. PubMed ID: 23241952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric investigation of CD40-CD40 ligand system in preeclampsia and normal pregnancy.
    Lukanov TH; Bojinova SI; Popova VS; Emin AL; Veleva GL; Gecheva SP; Konova EI
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):306-12. PubMed ID: 19221099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased concentration of soluble CD40 ligand in preeclampsia.
    Alacacioglu I; Ozcan MA; Piskin O; Yuksel F; Alacacioglu A; Demirkan F; Ozsan HG; Polat M; Ozgenc Y; Undar B
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):201-5. PubMed ID: 17456631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of neopterin, tumor necrosis factor-alpha and Interleukin-6 in preeclampsia: relationship with disease severity.
    Ozler A; Turgut A; Sak ME; Evsen MS; Soydinc HE; Evliyaoglu O; Gul T
    Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1707-12. PubMed ID: 23161044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia.
    Oron G; Ben-Haroush A; Hod M; Orvieto R; Bar J
    Obstet Gynecol; 2006 Apr; 107(4):896-900. PubMed ID: 16582129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microparticle-associated P-selectin reflects platelet activation in preeclampsia.
    Lok CA; Nieuwland R; Sturk A; Hau CM; Boer K; Vanbavel E; Vanderpost JA
    Platelets; 2007 Feb; 18(1):68-72. PubMed ID: 17365856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of thrombospondin-1 are decreased in HELLP syndrome.
    Stenczer B; Molvarec A; Szabó G; Szarka A; Fügedi G; Szijártó J; Rigó J
    Thromb Res; 2012 Apr; 129(4):470-3. PubMed ID: 22035632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular reactivity in patients with preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome.
    Fischer T; Schneider MP; Schobel HP; Heusser K; Langenfeld M; Schmieder RE
    Am J Obstet Gynecol; 2000 Dec; 183(6):1489-94. PubMed ID: 11120516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered lipid metabolism in preeclampsia and HELLP syndrome: links to enhanced platelet reactivity and fetal growth.
    Wetzka B; Winkler K; Kinner M; Friedrich I; März W; Zahradnik HP
    Semin Thromb Hemost; 1999; 25(5):455-62. PubMed ID: 10625202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia--possible role of platelet activation.
    Mellembakken JR; Solum NO; Ueland T; Videm V; Aukrust P
    Thromb Haemost; 2001 Nov; 86(5):1272-6. PubMed ID: 11816717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of the CD40-CD40 ligand system in pre-eclampsia.
    Lukanov TH; Bojinova SI; Emin AL; Veleva GL; Popova VS; Konova EI
    Int J Gynaecol Obstet; 2009 Jun; 105(3):257-60. PubMed ID: 19272596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between severe preeclampsia and abnormal expression of long-chain fatty acid oxidative enzyme].
    Sun XL; Yang Z; Wang JL; Sun MN; Wu SY; Wang XY
    Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(29):2026-9. PubMed ID: 22093928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAPP-A levels of late pregnancy in preeclampsia and HELLP syndrome.
    Atis A; Aydin Y; Basol E; Kaleli S; Turgay F; Goker N
    Arch Gynecol Obstet; 2012 Jan; 285(1):45-9. PubMed ID: 21533533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between plasma levels of soluble leukocyte differentiation antigens CD₄₀/CD₄₀ ligand and kidney damage in preeclamptic patients].
    Qin W; Zhan Y; Ye YH; Li C; Cui XN
    Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):582-6. PubMed ID: 22169515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating endothelial cell number and markers of endothelial dysfunction in previously preeclamptic women.
    Tuzcu ZB; Asicioglu E; Sunbul M; Ozben B; Arikan H; Koc M
    Am J Obstet Gynecol; 2015 Oct; 213(4):533.e1-7. PubMed ID: 26116870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between thrombophilic disorders and type of severe early-onset hypertensive disorder of pregnancy.
    Ganzevoort W; Rep A; De Vries JI; Bonsel GJ; Wolf H;
    Hypertens Pregnancy; 2007; 26(4):433-45. PubMed ID: 18066962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maternal and perinatal surgical complications in low platelet count for HELLP syndrome in severe preeclampsia-eclampsia in intensive care].
    Basavilvazo Rodríguez A; Pacheco Pérez C; Lemus Rocha R; Martínez Pérez JM; Martínez Martínez A; Hernández-Valencia M
    Ginecol Obstet Mex; 2003 Aug; 71():379-86. PubMed ID: 14619691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of circulating cell-free DNA levels in patients with severe preeclampsia and HELLP syndrome.
    Miranda ML; Macher HC; Muñoz-Hernández R; Vallejo-Vaz A; Moreno-Luna R; Villar J; Guerrero JM; Stiefel P
    Am J Hypertens; 2013 Dec; 26(12):1377-80. PubMed ID: 24103646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
    Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
    Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression and concentration of CD40 ligand in normal pregnancy and pre-eclampsia.
    Darmochwal-Kolarz D; Kolarz B; Surdacka A; Rolinski J; Leszczynska-Gorzelak B; Oleszczuk J
    J Reprod Immunol; 2009 Jan; 79(2):215-9. PubMed ID: 19201484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.